BLOOD PRODUCT RECALL INFORMATION The FDA is the agency responsible for notifying the public when medications are known to be unsafe.  Many people with hemophilia and bleeding disorders rely on clotting products derived from human blood. In order to create clotting products, blood needs to be cleaned and heated.  In the cleaning and heating process, many viruses and impurities are destroyed.  Clotting products, made from human blood, are known to be safer than ever.  Still, the risk of infection is present.   On occasion, clotting product testing shows the presence of  high risk viruses or other contaminants.  The FDA then notifies the public that a particular lot number or numbers have been withdrawn from the market.  Since some of these lots may have already been sold to families, hospitals, hemophilia treatment centers, and home care companies, this information is very important.  Information on these recalls and withdrawals of medications, as well as information on products used to treat hemophilia and related bleeding disorders is posted on the internet at the site linked below.  The Food and Drug Administration maintains this special listing of recalls and withdrawals as well as information on products.  You may be interested in keeping track of these advisories at http://www.fda.gov/cber/recalls.htm.   Setting the Standard of Homecare for the Bleeding Disorders Community AHF®, Inc. does not prescribe medications or give medical recommendations to individuals. AHF does not endorse or refer any particular individual to a specific HTC or medical provider.  It is best to obtain medical recommendations from your physician and/or your HTC.